Australia Lifestyle

Cochlear (ASX:COH) booked a 9% dip in underlying profit for H1 FY26, balancing the landmark Nucleus Nexa System launch against fiscal tightening and R&D costs.

Viva Leisure (ASX:VVA) has reported a powerhouse performance for the first half of fiscal year 2026, headlined by a 168% surge in statutory NPAT to $5.2 million.

San Francisco-based Life360 (ASX:360), the leading provider of family safety and connection mobile applications, reported record operational results for Q4 2025, driven by strong user growth and subscriber momentum.

Wellnex Life (ASX:WNX) has reported a significant turnaround in its financial performance for the six months ended Dec. 31, 2025, with H1 FY26 EBITDA rising $2.4 million.

Life360 (NASDAQ:LIF) (ASX:360) has completed the acquisition of advertising technology firm Nativo for approximately $120 million, paid 65% in cash and 35% in stock.

Control Bionics (ASX:CBL) has completed the acquisition of 100% of Neuro Elite Athletics, the US company behind the NeuroBounce athletic performance program.

Nutritional Growth Solutions (ASX:NGS) announced that, by mutual agreement, Stephen J. Turner will step down as CEO and Managing Director, effective Jan. 30, 2026.

Mayne Pharma Group (ASX:MYX) reported total net revenues of $165 million, a 5.5% decrease compared to the prior corresponding period.

Wellnex Life (ASX:WNX) provided shareholders with an update on its ongoing turnaround strategy.